Statements (21)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:CEO |
Benjamin Lightburn
|
| gptkbp:collaboratesWith |
academic institutions
|
| gptkbp:developedBy |
psilocybin-based medicines
|
| gptkbp:focusesOn |
psychedelic medicines
|
| gptkbp:foundedYear |
2020
|
| gptkbp:headquartersLocation |
gptkb:Vancouver,_Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
Filament Health
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:mission |
to advance the use of natural psychedelics for mental health
|
| gptkbp:notableProduct |
natural psilocybin
psychedelic extracts |
| gptkbp:publiclyTraded |
yes
|
| gptkbp:regulatoryMilestone |
first to receive Health Canada approval for natural psilocybin extraction
|
| gptkbp:specializesIn |
natural extraction of psychedelics
|
| gptkbp:stockExchange |
gptkb:OTCQB
|
| gptkbp:stockSymbol |
FLHLF
|
| gptkbp:website |
https://www.filament.health/
|
| gptkbp:bfsParent |
gptkb:Paul_Martino
|
| gptkbp:bfsLayer |
7
|